Jandhyala, Ravi http://orcid.org/0000-0002-7241-7476
Funding for this research was provided by:
GlaxoSmithKline
Article History
First Online: 9 January 2020
Compliance with Ethical Standards
:
: The research received an educational grant from GlaxoSmithKline. The open access fee was paid by Medialis Ltd.
: Ravi Jandhyala has previously worked as a pharmaceutical physician in the PAH therapy area at GlaxoSmithKline and is currently the managing director of Medialis Ltd, a medical affairs consultancy offering paid consultancy services surrounding clinical and post-authorisation research.